This compound is a protected nucleoside derivative featuring a triazole-substituted pyrimidine base and a furodioxolane core, commonly utilized as a pharmaceutical intermediate in nucleoside synthesis. Its structure incorporates an ester-linked isobutyrate group, which serves as a synthetic handle for further functionalization in drug development.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 2346620-54-8
N-benzoylcytidine
Pharmaceutical intermediate for nucleoside synthesis
5'-O-DMT-2'-O-TBDMS-Pseudouridine
Pharmaceutical intermediate for nucleoside synthesis
N-Acetyl-5'-o-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-2'-fluoroCytidine
Pharmaceutical intermediate for nucleoside synthesis
N-Benzoyl-2'-deoxyadenosine
Pharmaceutical intermediate for nucleoside synthesis
((3aR,4R,6R,6aR)-6-((4Z)-4-(Hydroxyimino)-2-oxo-3,4-dihydropyrimidin1(2H)-yl)-2,2-dimethyltetrahydro-2H-furo(3,4-d)(1,3)dioxol-4-yl)methyl2methylpropanoate
pharmaceutical intermediate
5-Amino-1,3,4-thiadiazole-2-thiol
Impurity in acetazolamide preparation
O-Methyl (S)-Noradrenaline
pharmaceutical intermediate for norepinephrine derivatives
1-(2,3-DICHLORO-4-HYDROXYPHENYL)BUTAN-1-ONE
Pharmaceutical intermediate
[(3aR,4R,6R,6aR)-2,2-dimethyl-4-[2-oxo-4-(1,2,4-triazol-1-yl)pyrimidin-1-yl]-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methyl 2-methylpropanoate
KHRVXGYHTALJEX-NMFUWQPSSA-N
CC(C)C(=O)OC[C@@H]1[C@@H]2[C@H]([C@@H](O1)N3C=CC(=NC3=O)N4C=NC=N4)OC(O2)(C)C
—